Literature DB >> 648762

Anti-insulin receptor antibodies inhibit insulin binding and stimulate glucose metabolism in skeletal muscle.

Y Le Marchand-Brustel, P Gorden, J S Flier, C R Kahn, P Freychet.   

Abstract

Autoantibodies against the insulin receptor are found in the serum of some patients with severe insulin resistance. The effects of one of these sera on insulin binding and on glucose transport and metabolism were investigated in the isolated mouse soleus muscle. Preincubation of muscles with the patient's serum resulted in an inhibition of subsequent 125I-insulin binding (half-maximal effect at 1:500 dilution) and in a two to three-fold stimulation of glucose transport and metabolism (half-maximal effect at 1:2000 dilution). The insulin-like effects were blocked by anti-human IgG, but not by anti-insulin antibodies. The magnitude of the serum effects on 2-deoxyglucose uptake and glycolysis was similar to that of insulin, but the effect on glycogen synthesis was smaller than that of insulin. It is suggested that the patient's serum and insulin promote glucose transport and glycolysis through a common pathway, but act differently on glycogen synthesis.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 648762     DOI: 10.1007/BF01223022

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  11 in total

1.  Autoantibodies to the insulin receptor. Effect on the insulin-receptor interaction in IM-9 lymphocytes.

Authors:  J S Flier; C R Kahn; D B Jarrett; J Roth
Journal:  J Clin Invest       Date:  1977-10       Impact factor: 14.808

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Insulin binding and effects in isolated soleus muscle of lean and obese mice.

Authors:  Y Le Marchand-Brustel; B Jeanrenaud; P Freychet
Journal:  Am J Physiol       Date:  1978-04

4.  Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action.

Authors:  C R Kahn; K Baird; J S Filier; D B Jarrett
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

5.  Thyroid-stimulating immunoglobulins in Graves' disease.

Authors:  B R Smith; R Hall
Journal:  Lancet       Date:  1974-08-24       Impact factor: 79.321

6.  Antibodies that impair insulin receptor binding in an unusual diabetic syndrome with severe insulin resistance.

Authors:  J S Flier; C R Kahn; J Roth; R S Bar
Journal:  Science       Date:  1975-10-03       Impact factor: 47.728

7.  The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.

Authors:  C R Kahn; J S Flier; R S Bar; J A Archer; P Gorden; M M Martin; J Roth
Journal:  N Engl J Med       Date:  1976-04-01       Impact factor: 91.245

8.  Characterization of antibodies to the insulin receptor: a cause of insulin-resistant diabetes in man.

Authors:  J S Flier; C R Kahn; D B Jarrett; J Roth
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

9.  Decreased basal, noninsulin-stimulated glucose uptake and metabolism by skeletal soleus muscle isolated from obese-hyperglycemic (ob/ob) mice.

Authors:  G S Cuendet; E G Loten; B Jeanrenaud; A E Renold
Journal:  J Clin Invest       Date:  1976-11       Impact factor: 14.808

10.  Direct method for detection and characterization of cell surface receptors for insulin by means of 125I-labeled autoantibodies against the insulin receptor.

Authors:  D B Jarrett; J Roth; C R Kahn; J S Flier
Journal:  Proc Natl Acad Sci U S A       Date:  1976-11       Impact factor: 11.205

View more
  20 in total

1.  Autoantibodies to the insulin receptor activate glycogen synthase in rat adipocytes.

Authors:  J C Lawrence; J Larner; C R Kahn; J Roth
Journal:  Mol Cell Biochem       Date:  1978-12-22       Impact factor: 3.396

Review 2.  Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action.

Authors:  R De Pirro; P Borboni; M A Marini; A Montemurro; G Sesti; R Lauro
Journal:  J Endocrinol Invest       Date:  1990-12       Impact factor: 4.256

3.  Direct demonstration that receptor crosslinking or aggregation is important in insulin action.

Authors:  C R Kahn; K L Baird; D B Jarrett; J S Flier
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

4.  Anti-insulin receptor antibodies mimic the effects of insulin on the activities of pyruvate dehydrogenase and acetylCoA carboxylase and on specific protein phosphorylation in rat epididymal fat cells.

Authors:  G J Belsham; R W Brownsey; W A Hughes; R M Denton
Journal:  Diabetologia       Date:  1980-04       Impact factor: 10.122

5.  Desensitization of the insulin receptor at an early postreceptor step by prolonged exposure to antireceptor antibody.

Authors:  F A Karlsson; E Van Obberghen; C Grunfeld; C R Kahn
Journal:  Proc Natl Acad Sci U S A       Date:  1979-02       Impact factor: 11.205

Review 6.  A partial view of the mechanism of insulin action.

Authors:  R M Denton; R W Brownsey; G J Belsham
Journal:  Diabetologia       Date:  1981-10       Impact factor: 10.122

7.  Antibody-induced desensitization of the insulin receptor. Studies of the mechanism of desensitization in 3T3-L1 fatty fibroblasts.

Authors:  C Grunfeld; E Van Obberghen; F A Karlsson; C R Kahn
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

8.  Control of muscle insulin receptors by the motor nerve.

Authors:  W W Hofmann; D H Nakano
Journal:  Experientia       Date:  1981-03-15

9.  Receptor-mediated insulin degradation and insulin-stimulated glycogenesis in cultured foetal hepatocytes.

Authors:  C Plas; B Desbuquois
Journal:  Biochem J       Date:  1982-02-15       Impact factor: 3.857

10.  Characterization of insulin receptors in patients with the syndromes of insulin resistance and acanthosis nigricans.

Authors:  R S Bar; M Muggeo; C R Kahn; P Gorden; J Roth
Journal:  Diabetologia       Date:  1980-03       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.